Andrew Simpson

Chairman and CEO / Board Member

Andrew has almost 30 years’ experience across a wide variety of business sectors and sizes from small entrepreneurial to large corporate and public companies. He was Group CEO of the Peel Group from 2006 to 2010.

Peel Group is a large private company in the U.K. with approximately $8 billion of businesses assets across the real estate, ports, airports, energy, media, telecoms and the environmental sectors. He left after achieving the strategic restructuring of the group by strengthening and creating key divisional teams; introducing key partners into several divisions (including the sale of stakes in its £1.6 billion ports business and £200 million airport business); materially increasing liquid assets by approx. £500 million; divesting non-core assets; and successfully managing £3 billion of debt funding across multiple facilities.

He was a main board director of Speedy Hire plc. (which became a FTSE 250 company) from 2003 to 2006 and was responsible for its development and expansion. This included seventeen acquisitions and several non-core divestments which saw the share price quadruple in value.

Andrew qualified as a Chartered Accountant with Price Waterhouse and spent eight years working in investment banking at Rothschild, advising on a wide variety of M&A transactions, debt and equity fundraisings, IPO’s and shareholder value issues. Andrew graduated first-class honors B.A. (Hons) in Accounting and Management.

Mark Hilz

Chief Operating Officer / Board Member

Mark has over 30 years’ experience as a President/CEO of multiple successful startup companies.

He was previously CEO of INX, a company that he was asked to start as a subsidiary for a public company. The technology infrastructure consulting company was started in 2000 and grew to $400M in revenue with 15 offices, 2,000 customers, and 500 employees. The Company was traded on the NASDAQ, completed multiple offerings and was successfully sold to private equity in December of 2011.

Prior to that Mr. Hilz founded and ran as CEO a technology logistics outsourcing firm, PC Service Source, that grew to over $160 million in revenue with 1,100 employees in an 8-year span. Mr. Hilz raised the startup capital from traditional venture capital sources and after 4 years of operations was successful in taking the Company public in an IPO as a NASDAQ global listed company as well as a successful follow on public offering.

Mark’s experience includes raising venture capital as well as multiple successful public offerings and numerous M&A transactions as both a buyer and a seller.

Danielle Watson

Chief Financial Officer

Danielle Watson has served as our Chief Financial Officer since April 2022. Prior to her appointment, Ms. Watson, a CPA, served as the Company’s Financial Controller since November 2021. Ms. Watson brings over 15 years of financial experience to her role. Before joining HeartSciences, Ms. Watson held senior leadership roles at Moss Adams, LLP from November 2007 to November 2021 where she provided audit and assurance services to both public and privately held companies with an emphasis in financial reporting, consolidations, strategic planning, purchase price accounting, and SEC reporting. Ms. Watson earned her Bachelor of Science, with a double concentration in accounting and finance from Texas Christian University and her Master of Science in accounting from the University of Texas at Arlington and is an active Certified Public Accountant in Texas.

Aaron Peterson

VP Research and Development

Aaron has 23 years of Engineering and Product Development experience, mostly in the Medical Device industry. Aaron has successfully productized multiple innovative technologies in the areas of Cardiac Rhythm Management, Neurostimulation and electrocardiography based devices. He was Director, R&D Systems Engineering for St. Jude Medical and was a Sr. Manager of Software Testing and Automation Tools Development for Boston Scientific (Advanced Bionics). Aaron is well versed in Design Controls and customizing product development processes to meet the needs of the business while remaining compliant with the standards and regulations in the medical device industry.

Carol Krieger

VP Clinical and Regulatory

Carol Krieger is an experienced Regulatory/Clinical professional with over 30 years of medical device experience in the clinical and regulatory areas. She has led and trained clinical and regulatory staff while holding strategic management positions in both large and small companies.

Her experience includes successfully developing and/or managing over 100 regulatory submissions to the FDA, including interacting with FDA product reviewers in two FDA divisions to facilitate approval of 510(k) and PMA submissions involving varied Class II and III products. Building clinical research/regulatory departments including the hiring, training and professional development of staff. She has substantial experience

She has designed and implemented multiple clinical protocols for the investigation of diagnostic medical devices for the purposes of FDA approval. Her experience includes reviewing product labeling, advertising and quality assurance documentation for compliance with FDA regulations.

Carol most recently served as the Director of Clinical Quality Assurance and Compliance at Becton Dickenson and Company. He previous experience also includes Boston Scientific Corp and Roche Diagnostic Systems, Inc..

Carol holds a Master of Science in Jurisprudence Degree from Seton Hall University School of Law, a Master of Business Administration Degree from Montclair State University, as well as a Bachelor of Science Degree in Medical Technology from Rutgers University.